切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MARK1 - sodium channel - 5-HT7 Receptors - CB1 Receptors

10 件产品

每页
清除全部
  1. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  2. Lamotrigine
    B2249 Lamotrigine
     1 Citation
    中文名: 拉莫三嗪
    Target: 5-HT receptors|sodium channel
    Summary: 5-HT抑制剂,钠通道阻断剂
      ≥12.3 mg/mL
      insoluble in H2O
  3. AM251
    B1427 AM251
    Target: CB1 Receptors
    Summary: 有效的CB1拮抗剂
      ≥55.5 mg/mL
      insoluble in H2O
  4. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  5. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  6. Rimonabant
    B1429 Rimonabant
     3 Citation
    中文名: 利莫那班
    Target: CB1 Receptors|CB2 Receptors
    Summary: CB1 受体拮抗剂
      ≥23.19 mg/mL
      insoluble in H2O
  7. Org 27569
    B1426 Org 27569
    Target: CB1 Receptors
    Summary: 大麻素CB1受体别构调节剂
      ≥13.95 mg/mL
      insoluble in H2O
  8. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  9. MRT67307 HCl
    A3635 MRT67307 HCl
    Target: TBK1|MARK1|NUAK1
    Summary: SIK/TBK-1/IKKe抑制剂
      ≥23.25 mg/mL
      ≥52.5 mg/mL
  10. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O

10 件产品

每页